United Therapeutics scraps development of esuberaprost after latestage study failure in PAH httpswww.firstwordpharma.comnode1633856Â $UTHR

United Therapeutics scraps development of esuberaprost after late-stage study failure in PAH https://www.firstwordpharma.com/node/1633856  $UTHR

12:57 EDT 8 Apr 2019 | FirstWord Pharma

United Therapeutics scraps development of esuberaprost after late-stage study failure in PAH https://www.firstwordpharma.com/node/1633856  $UTHR

More From BioPortfolio on "United Therapeutics scraps development of esuberaprost after late-stage study failure in PAH https://www.firstwordpharma.com/node/1633856  $UTHR"